David Osborn

David Osborn

Auto-generated profile, based on publicly available information

David Osborn

Division of Psychiatry, University College London, UK

Research Focus & Metrics

Academic Career Length

29Years (1998-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 August 2008 in BMC Psychiatry
Verified
Journal Article
Open access
PDF file
MKMichael King
Michael King
JSJoanna Semlyen
Joanna Semlyen
STSharon See Tai
Sharon See Tai
Helen KillaspyHelen Killaspy
Helen Killaspy
DODavid Osborn
David Osborn
INIrwin Nazareth
Irwin Nazareth
Lesbian, gay and bisexual (LGB) people may be at higher risk of mental disorders than heterosexual people. We conducted a systematic review and meta-analysis of the prevalence of mental disorder, substance misuse, suicide, suicidal ideation and deliberate self harm in LGB people. We searched Medline, Embase, PsycInfo, Cinahl, the Cochrane Library Database, the Web of Knowledge, the Applied Social Sciences Index and Abstracts, the International Bibliography of the Social Sciences, Sociological Abstracts, the Campbell Collaboration and grey literature databases for articles published January 1966 to April 2005. We also used Google and Google Scholar and contacted authors where necessary. We searched all terms related to homosexual, lesbian and bisexual people and all terms related to mental disorders, suicide, and deliberate self harm. We included papers on population based studies which contained concurrent heterosexual comparison groups and valid definition of sexual orientation and mental health outcomes. Of 13706 papers identified, 476 were initially selected and 28 (25 studies) met inclusion criteria. Only one study met all our four quality criteria and seven met three of these criteria. Data was extracted on 214,344 heterosexual and 11,971 non heterosexual people. Meta-analyses revealed a two fold excess in suicide attempts in lesbian, gay and bisexual people [pooled risk ratio for lifetime risk 2.47 (CI 1.87, 3.28)]. The risk for depression and anxiety disorders (over a period of 12 months or a lifetime) on meta-analyses were at least 1.5 times higher in lesbian, gay and bisexual people (RR range 1.54–2.58) and alcohol and other substance dependence over 12 months was also 1.5 times higher (RR range 1.51–4.00). Results were similar in both sexes but meta analyses revealed that lesbian and bisexual women were particularly at risk of substance dependence (alcohol 12 months: RR 4.00, CI 2.85, 5.61; drug dependence: RR 3.50, CI 1.87, 6.53; any substance use disorder RR 3.42, CI 1.97–5.92), while lifetime prevalence of suicide attempt was especially high in gay and bisexual men (RR 4.28, CI 2.32, 7.88). LGB people are at higher risk of mental disorder, suicidal ideation, substance misuse, and deliberate self harm than heterosexual people.

1 February 2007 in Archives of General Psychiatry
Verified
Journal Article
Open access
PDF file
DODavid P. J. Osborn
David P. J. Osborn
GLGus Levy
Gus Levy
INIrwin Nazareth
Irwin Nazareth
IPIrene Petersen
Irene Petersen
AIAmir Islam
Amir Islam
MKMichael B. King
Michael B. King
The physical health of people with severe mental illness (SMI) is of concern, particularly in relation to possible adverse effects of antipsychotic medication.1-3 Smoking, lifestyle, and poverty may play equally important roles, and the true burden of physical disease in this group remains unclear. Standardized mortality ratios for cardiovascular disease in schizophrenia are reported to be in the region of 104 (95% confidence interval [CI], 102-116)3 to 110 (95% CI, 105-115),2 but these estimates are limited to cohorts of people attending specific services in small geographical areas with short-term follow-up and considerable attrition. The figures are also compromised by small numbers of observed deaths and consequent low precision of the risk estimates. These limitations are summarized in Table 1.2-8 The literature is similarly conflicting regarding cancer mortality. Despite raised risk factors for neoplastic disease, mortality rates for some cancers are similar or even reduced in people with schizophrenia.3,9,10

1 June 2014 in The Lancet Psychiatry
Verified
Journal Article
Closed access
APAlexandra Pitman
Alexandra Pitman
DODavid Osborn
David Osborn
MKMichael King
Michael King
AEAnnette Erlangsen
Annette Erlangsen

1 September 2017 in The British Journal of Psychiatry
Verified
Journal Article
Open access
PDF file
JHJoseph F. Hayes
Joseph F. Hayes
LMLouise Marston
Louise Marston
KWKate Walters
Kate Walters
MKMichael B. King
Michael B. King
DODavid P. J. Osborn
David P. J. Osborn
Background: Bipolar disorder and schizophrenia are associated with increased mortality relative to the general population. There is an international emphasis on decreasing this excess mortality.Aims: To determine whether the mortality gap between individuals with bipolar disorder and schizophrenia and the general population has decreased.Method: A nationally representative cohort study using primary care electronic health records from 2000 to 2014, comparing all patients diagnosed with bipolar disorder or schizophrenia and the general population. The primary outcome was all-cause mortality.Results: Individuals with bipolar disorder and schizophrenia had elevated mortality (adjusted hazard ratio (HR) = 1.79, 95% CI 1.67–1.88 and 2.08, 95% CI 1.98–2.19 respectively). Adjusted HRs for bipolar disorder increased by 0.14/year (95% CI 0.10–0.19) from 2006 to 2014. The adjusted HRs for schizophrenia increased gradually from 2004 to 2010 (0.11/year, 95% CI 0.04–0.17) and rapidly after 2010 (0.34/year, 95% CI 0.18–0.49).Conclusions: The mortality gap between individuals with bipolar disorder and schizophrenia, and the general population is widening.

3 March 2015 in Acta Psychiatrica Scandinavica
Verified
Journal Article
Open access
PDF file
JHJ. F. Hayes
J. F. Hayes
JMJ. Miles
J. Miles
KWK. Walters
K. Walters
MKM. King
M. King
DOD. P. J. Osborn
D. P. J. Osborn
Objective To review and complete meta‐analysis of studies estimating standardised mortality ratios (SMRs) in bipolar affective disorder (BPAD) for all‐cause and cause‐specific mortalities. Method Cause‐specific mortality was grouped into natural and unnatural causes. These subgroups were further divided into circulatory, respiratory, neoplastic and infectious causes, and suicide and other violent deaths. Summary SMRs were calculated using random‐effects meta‐analysis. Heterogeneity was examined via subgroup analysis and meta‐regression. Results Systematic searching found 31 studies meeting inclusion criteria. Summary SMR for all‐cause mortality = 2.05 (95% CI 1.89–2.23), but heterogeneity was high (I2 = 96.2%). This heterogeneity could not be accounted for by date of publication, cohort size, mid‐decade of data collection, population type or geographical region. Unnatural death summary SMR = 7.42 (95% CI 6.43–8.55) and natural death = 1.64 (95% CI 1.47–1.83). Specifically, suicide SMR = 14.44 (95% CI 12.43–16.78), other violent death SMR = 3.68 (95% CI 2.77–4.90), deaths from circulatory disease = 1.73 (95% CI 1.54–1.94), respiratory disease = 2.92 (95% CI 2.00–4.23), infection = 2.25 (95% CI 1.70–3.00) and neoplasm = 1.14 (95% CI 1.10–1.21). Conclusion Despite considerable heterogeneity, all summary SMR estimates and a large majority of individual studies showed elevated mortality in BPAD compared to the general population. This was true for all causes of mortality studied.

1 September 2015 in BMJ
Verified
Journal Article
Open access
PDF file
RSRory Sheehan
Rory Sheehan
AHAngela Hassiotis
Angela Hassiotis
KWKate Walters
Kate Walters
DODavid Osborn
David Osborn
ASAndre Strydom
Andre Strydom
LHLaura Horsfall
Laura Horsfall
Objectives To describe the incidence of recorded mental illness and challenging behaviour in people with intellectual disability in UK primary care and to explore the prescription of psychotropic drugs in this group. Design Cohort study. Setting 571 general practices contributing data to The Health Improvement Network clinical database. Participants 33 016 adults (58% male) with intellectual disability who contributed 211 793 person years’ data. Main outcome measures Existing and new records of mental illness, challenging behaviour, and psychotropic drug prescription. Results 21% (7065) of the cohort had a record of mental illness at study entry, 25% (8300) had a record of challenging behaviour, and 49% (16 242) had a record of prescription of psychotropic drugs. During follow-up, the rate of new cases of mental illness in people without a history at cohort entry was 262 (95% confidence interval 254 to 271) per 10 000 person years and the rate of challenging behaviour was 239 (231 to 247) per 10 000 person years. The rate of new psychotropic drug prescription in those without a previous history of psychotropic drug treatment was 518 (503 to 533) per 10 000 person years. Rates of new recording of severe mental illness declined by 5% (95% confidence interval 3% to 7%) per year (P<0.001), and new prescriptions of antipsychotics declined by 4% (3% to 5%) per year P<0.001) between 1999 and 2013. New prescriptions of mood stabilisers also decreased significantly. The rate of new antipsychotic prescribing was significantly higher in people with challenging behaviour (incidence rate ratio 2.08, 95% confidence interval 1.90 to 2.27; P<0.001), autism (1.79, 1.56 to 2.04; P<0.001), and dementia (1.42, 1.12 to 1.81; P<0.003) and in those of older age, after control for other sociodemographic factors and comorbidity. Conclusions The proportion of people with intellectual disability who have been treated with psychotropic drugs far exceeds the proportion with recorded mental illness. Antipsychotics are often prescribed to people without recorded severe mental illness but who have a record of challenging behaviour. The findings suggest that changes are needed in the prescribing of psychotropics for people with intellectual disability. More evidence is needed of the efficacy and safety of psychotropic drugs in this group, particularly when they are used for challenging behaviour.